Becker's Healthcare December 16, 2025
The Centers for Medicare & Medicaid Services (CMS) finalized the 2026 Outpatient Prospective Payment System (OPPS) rule with a wide range of policy updates that extend beyond core payment changes.
A December 10 Coronis Health blog post breaks down a recent CMS fact sheet that outlines several additional provisions affecting drug payments, non-opioid pain management, domestic drug production incentives and hospital price transparency requirements.
Here are four takeaways:
1. CMS to survey hospital drug acquisition costs
As required under Section 1833(t)(14)(D)(ii) of the Social Security Act, CMS will conduct a nationwide survey of hospital acquisition costs for separately payable outpatient drugs. The survey will include all hospitals paid under OPPS and is expected to be completed by early calendar...







